Company news
Sichuan Kelun Pharmaceutical Co., Ltd. Class A (SZSE:002422) news
Sichuan Kelun Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Dec 4, 2025: Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership…
Press releases & updates
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
December 4, 2025
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
October 18, 2025
Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting
April 24, 2025